Search Results for "Molecular Markers Cervical Cancer"
Original Source: Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis
The purpose of this study is to: 1. make p16INK4A as a cervical cancer screening of tumor markers, cytology improve existing diagnostic sensitivity, specificity, repeatability and validity, so as to effectively prompted the early discovery and diagnosis of cervical cancer. 2. reduce screening costs, screening and benefits into quantitative evaluation, for our country to develop cervical cancer prevention and control strategy to provide a reliable...
Matching Channels
Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated...
Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...
Matching News
Quest launches molecular cervical cancer TERC test
Quest Diagnostics has introduced a molecular cervical cancer test based on National Institutes of Health's TERC gene marker to identify molecular changes to cervical cells that increase the chance of...
To coincide with Cervical Cancer Prevention Week (20-26th January), Robert Music provides us with an overview of cervical cancer, including how it can be prevented. What is cervical cancer? Cervical...
Molecular Markers Identify Oral Cancer Risk
A group of molecular markers have been identified that can help clinicians determine which patients with low-grade oral premalignant...
Molecular Test Improves Evaluation of Cervical Cancer Risk
A new laboratory test identifies molecular changes to cervical cells that increase the likelihood that a woman may develop...
What Is Cervical Screening? What Is The Pap Test?
Cervical cancer is one of the few preventable cancers. Pre-cancerous cells can be detected before they have developed into cancer. Health authorities say that cervical screening is an important part o...
Just A Single HPV Protein Required For Cervical Cancer And Pre-Cancer Cervical Growths
Human papillomavirus (HPV) has long been implicated in cervical cancer, but details of how it happens have remained a mystery. Now researchers at the University of Wisconsin-Madison have found that a...
Quest Diagnostics announces availability of TERC test for cervical cancer
Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical...
Study investigates molecular markers in drug-resistant ovarian cancer
A new study by TCD researchers investigates drug-resistant ovarian cancer cells. The findings which have been recently published in the international publication, PLoS One will increase understanding...
Matching PubMed Articles
The Association Between Cervical Abnormalities and Attitudes Toward Cervical Cancer Prevention.
Abstract Background: We investigated whether a history of cervical abnormalities predicts responses to cervical cancer prevention for women and their daughters. Methods: In 2007, we interviewed 832 mo...
At the beginning of the 20th Century, cervical cancer was the leading cause of death from cancer in women. A marked decline in cervical cancer has been observed since the 1960s, in parallel with the i...
Abnormal Immunoexpression of Cell Adhesion Molecules (CAMs) in Cervical Cancer.
The purpose of this study was to examine the immunoexpression of cell adhesion molecules (CAMs) E-cadherin, CD44s, and CD44v3 in cervical cancer and compare it with that in benign exo-endocervical tis...
Sex steroids and cervical cancer.
During the 19th century, studies indicated that reproductive events were involved in cervical cancer. Human papillomavirus (HPV) infection is a prerequisite for development of cancer, but co-factors,...
Distribution of CCND1 A870G Polymorphism in Patients with Advanced Uterine Cervical Carcinoma.
We examined the distribution of the CCND1 A870G (rs9344) polymorphic variant in patients with cervical cancer (n = 129) and healthy individuals (n = 288) in a sample of a Polish cohort. We showed that...
